Skip to main content

Biopharma Startups

Updated July 2026

Companies in the biopharma sector developing innovative solutions and technologies.

Explore 854 recently funded biopharma companies with verified founder contact information and fundraising data.

Total Companies
854
Total Funding
$881.0M
Avg Funding
$35.2M
Global Reach
6
countries

Top Cities for Biopharma

New York
Santa Barbara
Storrs Mansfield
Singapore
Cambridge
Tokyo

Recently Funded Companies

Export
New York, United States

Axsome Therapeutics is a biopharmaceutical company that develops therapies for the management and treatment of neurological disorders.

$570.0M raised
May 2025

Founder Contacts

30,000+ verified contacts

Santa Barbara, United States

CancerVAX Biotech is a biotechnology company that develops universal cancer treatment using the body’s immune system.

$903K raised
May 2026

Founder Contacts

30,000+ verified contacts

Storrs Mansfield, United States

DIANT Pharma develops continuous processing technology for nanoparticle drug products and vaccines.

$292K raised
May 2025

Founder Contacts

30,000+ verified contacts

Singapore, Singapore

KYAN Therapeutics is a clinical-stage AI company leveraging its proprietary technology platforms to transform the way patients are treated.

May 2024

Founder Contacts

30,000+ verified contacts

Cambridge, United Kingdom

Tolemy Bio develops AI-driven tools to design, optimize, and control cell culture processes for advanced therapies.

$1.6M raised
May 2026

Founder Contacts

30,000+ verified contacts

Tokyo, Japan

Varinos is a biotechnology company that offers new genomic testing and contract analysis services.

$7.9M raised
May 2026

Founder Contacts

30,000+ verified contacts

Alpine, United States

Snow Canyon Therapeutics is a biotechnology firm that develops treatments to reverse chronic diseases by altering the inflammatory pathway.

$2.6M raised
May 2022

Founder Contacts

30,000+ verified contacts

Hamilton, Canada

Stoked Bio is a biotechnology company that focuses on discovering medicines to combat drug-resistant diseases.

$366K raised
May 2026

Founder Contacts

30,000+ verified contacts

Shorewood, United States

Niche Biopharmaceuticals biopharma company that offers anti-infective immunomodulatory therapeutics for antiviral treatment.

$200K raised
May 2026

Founder Contacts

30,000+ verified contacts

London, United Kingdom

Celadon's objective is to improve the quality of life for the most vulnerable people by producing cannabis-based medications.

$2.6M raised
May 2024

Founder Contacts

30,000+ verified contacts

Boston, United States

Invetx is a veterinary therapeutics company that develops protein-based therapeutics for the treatment of various animal diseases.

$60.5M raised
May 2022

Founder Contacts

30,000+ verified contacts

Wilmington, United States

DeepCyte is a biotechnology company that offers predictive products for toxicology using single-cell metabolomics technology.

$1.5M raised
Apr 2026

Founder Contacts

30,000+ verified contacts

New York, United States

Bond Biosciences is a biopharmaceutical company

$5.9M raised
Apr 2026

Founder Contacts

30,000+ verified contacts

Gebze, Turkey

PhiTech Bioinformatics provides AI-powered multi-omics based diagnostic decision support for precision medicine.

$2.4M raised
Apr 2026

Founder Contacts

30,000+ verified contacts

Gebze, Turkey

PhiTech Bioinformatics provides AI-powered multi-omics based diagnostic decision support for precision medicine.

$2.4M raised
Apr 2026

Founder Contacts

30,000+ verified contacts

Gebze, Turkey

PhiTech Bioinformatics provides AI-powered multi-omics based diagnostic decision support for precision medicine.

$2.4M raised
Apr 2026

Founder Contacts

30,000+ verified contacts

Gebze, Turkey

PhiTech Bioinformatics provides AI-powered multi-omics based diagnostic decision support for precision medicine.

$2.4M raised
Apr 2026

Founder Contacts

30,000+ verified contacts

San Diego, United States

Arnatar Therapeutics is a biopharmaceutical company that specializes in the development of novel nucleic acid medications.

$52.0M raised
Apr 2024

Founder Contacts

30,000+ verified contacts

Uruma, Japan

FullStem is a company specializing in high-density mass culture technology for stem cells.

Apr 2024

Founder Contacts

30,000+ verified contacts

Jupiter, United States

BioCurity Pharmaceuticals is a biopharmaceutical company developing drugs to prevent side effects of radiation therapy for cancer patients.

$75K raised
Apr 2022

Founder Contacts

30,000+ verified contacts

Oxford, United Kingdom

Fermtech provides equipment for precision fermentation companies to scale production processes.

$3.3M raised
Apr 2026

Founder Contacts

30,000+ verified contacts

San Diego, United States

Oxeia Biopharmaceuticals is a clinical stage biotech company.

$1.5M raised
Apr 2026

Founder Contacts

30,000+ verified contacts

Houston, United States

Stramsen Biotech is a biopharmaceutical company that uses natural plant based approach to develop medicines.

$25.0M raised
Apr 2025

Founder Contacts

30,000+ verified contacts

Farmington Hills, United States

Opus Genetics a clinical-stage biopharmaceutical company, develops and commercializes therapies for patients with ophthalmic disorders.

$35.0M raised
Apr 2026

Founder Contacts

30,000+ verified contacts

Cambridge, United States

Stipple Bio is a biotechnology company that offers cellular profiling and target discovery with epitope resolution.

$100.0M raised
Apr 2026

Founder Contacts

30,000+ verified contacts

Showing 251 to 275 of 854 companies

About the Biopharma Startup Ecosystem

The biopharma sector is an active area of startup innovation and venture capital investment. Companies in this space are developing new technologies, platforms, and services that address evolving market needs and create new business opportunities.

Funding Trends in Biopharma

Biopharma companies raise capital across various funding stages, from early seed rounds to late-stage growth financing. Investor interest in this sector is driven by the size of the addressable market, the pace of technology adoption, and the potential for scalable business models.

Growth Outlook

The biopharma sector is expected to continue evolving as technology advances, market dynamics shift, and new opportunities emerge. Companies that demonstrate strong product-market fit, efficient growth, and clear competitive advantages are well-positioned to attract continued investment.

Biopharma Funding Breakdown

Here is how funding is distributed among the 854 biopharma companies tracked in the VCBacked database.

Average Funding
$35.2M
Total Funding Tracked
$881.0M
Countries Represented
6

Distribution by Funding Stage

Other25 companies

Top Cities for Biopharma

1.Gebze
4 companies$9.6M
2.New York
2 companies$575.9M
3.Cambridge
2 companies$101.6M
4.San Diego
2 companies$53.5M
5.Santa Barbara
1 companies$903K

Related Industries

Companies in the biopharma sector often overlap with or complement businesses in adjacent industries. Exploring related verticals can help you discover additional companies, identify partnership opportunities, and understand the broader competitive landscape.

Ready to Connect with Biopharma Startups?

Perfect for: B2B sales teams targeting biopharma companies, investors exploring sector opportunities, and service providers looking for funded companies ready to scale.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked